Two novel mutations, L490R and V561X, of transferrin receptor 2 gene in Japanese patients with hemochromatosis

Haematologica

Volumn 90, Issue 3, 2005, Pages 302-306

  Koyama, Chizu ^a   Wakusawa, Shinya ^a   Hayashi, Hisao ^a   Suzuki, Rie ^a   Yano, Motoyoshi ^b   Yoshioka, Kentaro ^b   Kozuru, Mitsuo ^c   Takayama, Yoshihiro ^d   Okada, Toshihide ^e   Mabuchi, Hiroshi ^e  

^a HOKURIKU UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ASO IIZUKA HOSPITAL   (Japan)

^d Hokuriku Hospital   (Japan)

^e KANAZAWA UNIVERSITY   (Japan)

Author keywords

Cirrhosis; Diabetes; Iron; Liver; Non HFE

Indexed keywords

TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON METABOLISM; IRON OVERLOAD; LIVER CIRRHOSIS; SKIN PIGMENTATION;

ADULT; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY, MOLECULAR; FEMALE; HEMOCHROMATOSIS; HUMANS; JAPAN; MALE; MIDDLE AGED; MUTATION, MISSENSE; RECEPTORS, TRANSFERRIN;

EID: 20144381350     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
2. Gunshin H, Mackenzie B, Berger UV, Gunshin Y, Romero MF, Boron WF, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-8.
3. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, et al. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 1999; 274:20826-32.
4. Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001;28:213-4.
5. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 2001;98:8160-2.
6. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
7. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8
8. De Gobbi M, Daraio F, Oberkanins C, Moritz A, Kury F, Fiorelli G, et al. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload. Haematologica 2003;88:396-401.
9. Sohda T, Yanai J, Soejima H, Tamura K. Frequencies in the Japanese population of HFE gene mutations. Biochem Genet 1999;37:63-8.
10. Shiono Y, Ikeda R, Hayashi H, Wakusawa S, Sanae F, Takikawa T, et al. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med 2001; 40:852-6.
11. Pietrangelo A. Hereditary hemochromatosis. A new look at an old disease. N Engl J Med 2004;350: 2383-97.
12. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33: 21-2.
13. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, et al. The gene encoding transferrin receptor 2 is mutated in a new type of hemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5.
14. Roetto A, Totaro A, Piperno A, Piga A, Longo F, Garozzo G, et al. New mutation inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 2001;97:2555-60.
15. Mattman A, Huntsman D, Lockitch G, Langlois S, Buskard N, Ralston D, et al. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation. Blood 2002;100:1075-7.
16. Girelli D, Bozzini C, Roetto A, Alberti F, Daraio F, Colombari R, et al. Clinical and histopathological findings in a family with hemochromatosis type 3, carrying a new mutation in transferrin receptor 2 gene. Gastroenterology 2002;122:1295-302.
17. Barton EH, West PA, Rivers CA, Barton JC, Acton RT. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload. Blood Cells Mol Dis 2001;27: 279-84.
18. Hattori A, Wakusawa S, Hayashi H, Harashima A, Sanae F, Kawanaka M, et al. AVAQ 594-597 deletion of the TfR2 gene in a Japanese family with hemochromatosis. Hepatol Res 2003;26: 154-6.
19. Sohda T, Okubo R, Kamimura S, Ohkawara T. Hemochromatosis with HFE gene mutation in a Japanese patient. Am J Gastroenterol 2001;96:2487-8.
20. Kato J, Fujikawa K, Kanda M, Fukuda N, Sasaki K, Takayama T, et al. A mutation in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet 2001;69:191-7.
21. Pipemo A, Roetto A, Mariani R, Pelucchi S, Corengia C, Daraio F, et al. Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. Haematologica 2004;89:359-60.
22. Hofmann WK, Tong XJ, Ajioka RS, Kushner JP, Koeffler HP. Mutation analysis of transferring-receptor 2 in patients with atypical hemochromatosis. Blood 2002;100:1099-100.
23. Biasiotto G, Belloli S, Ruggeri G, Zanella I, Gerardi G, Corrado M, et al. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin Chem 2003;49:1981-8.
24. Lee PL, Halloran C, West C, Beutler E. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol Dis 2001; 27:285-9.